Cleverpath
ActiveSummary
Cleverpath has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €77,524 and a net result of €63,349. Its solvency ranks better than 81% of 20,589 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
- Equity
- €77,524
- Profit
- €63,349
Why 98raises riskFounded in 2024lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 8.24, cash €71,702Equity €77,524 (88.1% of total assets)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 88% on liquidity, 80% on profitability and 98% on growth.
The bankruptcy probability was computed on 22-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 2 accounts on average 28 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · micro…
- Liquidity more than doubledcurrent ratio 8.24
- Annual accounts filedfinancial year 2024 · micro…
Financials · financial year 2025, micro format
2025 annual accounts filed late (28 days) Filed on 28 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00490252.
2024 to 2025, 2 financial years
The operating result rises in 2025; 2025 is 440% above 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Peer companies
Historical observationOf the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.8% are still going.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Turnover70 | €0 | - | - |
| Goods, raw materials, services and sundry goods60/61 | €0 | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €232 | €1,095 | ▲ 372% |
| Other operating charges640/8 | - | €171 | - |
| Gross operating margin9900 | €15,061 | €81,344 | ▲ 440% |
| Operating profit (loss)9901 | €14,829 | €80,078 | ▲ 440% |
| Financial income75/76B | - | €28 | - |
| Recurring financial income75 | - | €28 | - |
| Financial charges65/66B | - | €9 | - |
| Recurring financial charges65 | - | €9 | - |
| Profit (loss) for the period before taxes9903 | €14,829 | €80,097 | ▲ 440% |
| Income taxes67/77 | €3,054 | €16,747 | ▲ 448% |
| Profit (loss) for the period9904 | €11,775 | €63,349 | ▲ 438% |
| Profit (loss) for the period to be appropriated9905 | €11,775 | €63,349 | ▲ 438% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €20,205 | €87,968 | ▲ 335% |
| Fixed assets21/28 | €3,054 | €1,959 | ▼ 35.9% |
| Tangible fixed assets22/27 | €3,054 | €1,959 | ▼ 35.9% |
| Furniture and vehicles24 | €3,054 | €1,959 | ▼ 35.9% |
| Current assets29/58 | €17,151 | €86,009 | ▲ 401% |
| Amounts receivable within one year40/41 | €8,500 | €9,800 | ▲ 15.3% |
| Trade receivables40 | €8,500 | €9,800 | ▲ 15.3% |
| Cash at bank and in hand54/58 | €4,290 | €71,702 | ▲ 1,571% |
| Deferred charges and accrued income490/1 | €4,361 | €4,507 | ▲ 3.3% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €20,205 | €87,968 | ▲ 335% |
| Equity10/15 | €14,175 | €77,524 | ▲ 447% |
| Contributions10/11 | €2,400 | €2,400 | = |
| Profit (loss) carried forward14 | €11,775 | €75,124 | ▲ 538% |
| Amounts payable17/49 | €6,031 | €10,443 | ▲ 73.2% |
| Amounts payable within one year42/48 | €6,031 | €10,443 | ▲ 73.2% |
| Trade debts44 | €1,643 | €1,658 | ▲ 0.9% |
| Suppliers440/4 | €1,643 | €1,658 | ▲ 0.9% |
| Taxes, remuneration and social security45 | €3,054 | €7,739 | ▲ 153% |
| Taxes450/3 | €3,054 | €7,739 | ▲ 153% |
| Remuneration and social security454/9 | €0 | - | - |
| Other amounts payable47/48 | €1,334 | €1,047 | ▼ 21.5% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €11,775 | €63,349 | ▲ 438% |
| + Depreciation and write-downs630 | €232 | €1,095 | ▲ 372% |
| Operating cash flow (approximation) | €12,007 | €64,445 | ▲ 437% |
| Investment in fixed assets (approximation) | - | €0 | - |
| Change in cash | - | €67,412 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (2)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 28-08-2026 | 2026-00490252 |
| 31-12-2024 | micro format | 28-08-2025 | 2025-00426046 |
Similar companies · same sector, comparable size
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| LURQUIN Eveline |
|
Owners and capital
Capital and shareholders
- LURQUIN Eveline 2,400 shares (100%) · €2,400 in cash
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 17-10-2024 Incorporation · €2,400 · 2,400 shares
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
Acts, filings and financial milestones
17-10
Gazette deed
IncorporationAppointment: LURQUIN Eveline (director) · Founder · Registered office clause7 facts ▸
- Incorporation, 15-10-2024
- Founder, LURQUIN Eveline
- Registered office clause, “3000 Leuven, Fonteinstraat 139 bus 0402” (deed in Dutch)
- Board rule, 1
- Director appointment, LURQUIN Eveline (director (not named in the articles))
- Pre-incorporation commitments, “takeover, alle verbintenissen, verplichtingen en activiteiten ondernomen in naam en voor rekening van vennootschap in oprichting” (deed in Dutch)
- Founding capital, €2,400
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 23 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 24505F0906/00T000 | Flanders | 1,585 m² | 1 · 191 m² | 27.9 m · 9 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “De uitoefening van de geneeskunde door de artsen-aandeelhouders als arts-specialist, met specialisatie in de pathologische anatomie; Alle…” (deed in Dutch)
8 activities (deed in Dutch)
- De uitoefening van de geneeskunde door de artsen-aandeelhouders als arts-specialist, met specialisatie in de pathologische anatomie
- Alle werkzaamheden en rechtshandelingen verrichten die van aard zijn de verwezenlijking van haar voorwerp te bevorderen
- Deelnemen aan alle ondernemingen die een gelijkaardig voorwerp nastreven
- Alle hoegenaamde roerende en onroerende handelingen verrichten, die verband houden met haar voorwerp of die kunnen bijdragen tot de verwezenlijking ervan
- Roerende en onroerende goederen en rechten verwerven en beheren en rechtshandelingen dienaangaande stellen
- Het aanleggen, het oordeelkundig uitbouwen en beheren van een roerend patrimonium
- Alle verrichtingen met betrekking tot roerende goederen en rechten, van welke aard ook, zoals het verwerven door inschrijving of aankoop en het beheren van aandelen, obligaties, kasbons of andere roerende waarden, van welke vorm ook, van Belgische of buitenlandse, bestaande of nog op te richten rechtspersonen en ondernemingen
- Risicovolle of speculatieve beleggingen aangaan, overeenkomstig een zeer dynamisch risicoprofiel
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Cleverpath
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- One provision in the deed
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Bestuursorgaan, Zij worden door de algemene vergadering benoemd” (deed in Dutch)4 more provisions on this in the deed
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Aandelen moeten bij hun uitgifte worden volgestort, In geval van een enige aandeelhouder-bestuurder, bepaalt deze laatste vrij, naargelang…” (deed in Dutch)“Op naam, vanaf inschrijving in het register der aandeelhouders” (deed in Dutch)
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “De overdracht van de aandelen gebeurt tegen nominale waarde verhoogd met het aandeel in de reserves zoals deze blijkt uit de laatste…” (deed in Dutch)
- Share issue ruleHow and by whom new shares can be issued.
- “De uitgegeven aandelen moeten volledig en, niettegenstaande andersluidende bepaling, onvoorwaardelijk zijn geplaatst., De…” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- “TITEL V. ALGEMENE VERGADERING Artikel 15. Organisatie en bijeenroeping Ieder jaar wordt een gewone algemene vergadering van aandeelhouders…” (deed in Dutch)
- Meeting noticeHow and how far ahead shareholders are invited to a meeting; by law at least fifteen days.
- One provision in the deed
- Meeting accessWho may attend the meeting and what is needed to be admitted.
- One provision in the deed
- Meeting procedureHow the meeting runs, from opening to minutes.
- One provision in the deed
- Meeting agendaHow the agenda is set and who may add items to it.
- One provision in the deed
- Voting ruleWhich majority the meeting decides by, for example a simple or a special majority.
- One provision in the deed
- Remote participationWhether shareholders may take part in the meeting remotely.
- One provision in the deed
Oversight and winding up
- Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
- Auditor ruleHow a statutory auditor is appointed and what they check, if the company has one.
- One provision in the deed
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Beslissing algemene vergadering, vormen vereist voor statutenwijziging” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Indien geen andere vereffenaar benoemd, bestuurder(s) in functie” (deed in Dutch)